| __timestamp | Dr. Reddy's Laboratories Limited | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 189101000 |
| Thursday, January 1, 2015 | 17449000000 | 96351000 |
| Friday, January 1, 2016 | 17834000000 | 95967000 |
| Sunday, January 1, 2017 | 19551000000 | 112171000 |
| Monday, January 1, 2018 | 18265000000 | 182257000 |
| Tuesday, January 1, 2019 | 15607000000 | 336964000 |
| Wednesday, January 1, 2020 | 15410000000 | 547851000 |
| Friday, January 1, 2021 | 16541000000 | 693716000 |
| Saturday, January 1, 2022 | 17482000000 | 891813000 |
| Sunday, January 1, 2023 | 19381000000 | 1044071000 |
| Monday, January 1, 2024 | 22873000000 | 910408000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Dr. Reddy's Laboratories Limited and Exelixis, Inc. exemplify contrasting approaches to R&D investment over the past decade. From 2014 to 2023, Dr. Reddy's consistently allocated a significant portion of its resources to R&D, with expenditures growing by approximately 85%, peaking in 2023. This commitment underscores their strategy to maintain a robust pipeline of new drugs and therapies.
Conversely, Exelixis, Inc. has shown a more modest yet steady increase in R&D spending, with a notable 450% rise from 2014 to 2023. This growth reflects their focused approach to developing targeted cancer therapies. However, data for 2024 is missing, leaving a gap in understanding their future trajectory. These insights reveal the strategic priorities of each company, highlighting the diverse paths to innovation in the pharmaceutical industry.
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited
Research and Development Investment: Neurocrine Biosciences, Inc. vs Exelixis, Inc.
Research and Development Investment: Viatris Inc. vs Exelixis, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Ultragenyx Pharmaceutical Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and Galapagos NV Allocate Funds
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Novavax, Inc.
Exelixis, Inc. or Blueprint Medicines Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and Ascendis Pharma A/S
Analyzing R&D Budgets: Exelixis, Inc. vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and Geron Corporation